European patent grant for IMP321 in cancer
Filed with ASX · · 2 pages · English
Story so far
Earlier from Immutep
- Japanese Patent Grant for IMP731 Antibody
- Japanese Patent Grants For IMP321 In Infectious Disease
- PRR & Monash Uni receive funding grant for LAG-3 Research
- Appendix 4E & 2017 Full Year Statutory Accounts
- French government research cash rebate of A$1.3M received
Later from Immutep
- Immutep receives USD1M milestone payment from EOC
- Outcome of DSMB Safety Review & Extension of TACTI-mel
- Immutep receives A$686,704 R&D Tax Incentive
- US patent grant for IMP701 antibody
- Immutep raises A$6.85M through institutional placement
Follow Immutep into a list and get an email when it puts out news.
Follow Immutep